KRAS and non-small cell lung carcinoma: ROCK signaling has been shown to be upregulated in KRAS mutant NSCLC cell lines, animal models, and tumor tissues derived from patients, and it is thought that the increased stiffness of the extracellular matrix of the tumor, combined with hypoxia, activates the RhoA/ROCK pathway [21].